Compass Financial Management LLC Acquires Shares of 3,098 Humana Inc. $HUM

Key Points

• Compass Financial Management purchased 3,098 Humana shares worth approximately $1.23 million in the second quarter. Institutional investors collectively own 92.38% of the company.
• Analyst sentiment is mixed, with 14 Buy, 15 Hold and one Sell rating; Humana has an average rating of Hold and an average price target of $403.91.
• Humana exceeded quarterly expectations, reporting $7.61 in adjusted earnings per share and $40.89 billion in revenue, while revenue increased 26.2% year over year. The company also declared a quarterly dividend of $0.885 per share.

Compass Financial Management LLC bought a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,098 shares of the insurance provider's stock, valued at approximately $1,229,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Wilkerson Advisory Group LLC increased its stake in shares of Humana by 24.6% in the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider's stock worth $66,000 after acquiring an additional 33 shares in the last quarter. Bogart Wealth LLC boosted its stake in Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Fiduciary Alliance LLC grew its holdings in Humana by 0.9% in the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider's stock worth $976,000 after purchasing an additional 49 shares during the period. Horizon Investments LLC grew its holdings in Humana by 2.5% in the fourth quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider's stock worth $573,000 after purchasing an additional 55 shares during the period. Finally, Johnson Financial Group Inc. bought a new position in shares of Humana during the second quarter valued at approximately $26,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on HUM shares. Truist Financial lifted their target price on shares of Humana from $320.00 to $415.00 and gave the company a "hold" rating in a report on Tuesday, July 14th. William Blair assumed coverage on Humana in a research report on Wednesday, May 20th. They set an "outperform" rating for the company. Raymond James Financial cut Humana from an "outperform" rating to a "market perform" rating in a research note on Thursday, July 30th. TD Cowen boosted their target price on Humana from $350.00 to $370.00 and gave the stock a "hold" rating in a report on Friday, July 31st. Finally, Wells Fargo & Company raised Humana from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $227.00 to $502.00 in a research note on Monday, July 13th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Humana currently has an average rating of "Hold" and an average target price of $403.91.

Humana Stock Down 1.4%

Shares of Humana stock opened at $400.70 on Friday. The company has a 50-day simple moving average of $388.44 and a two-hundred day simple moving average of $296.00. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market capitalization of $48.12 billion, a PE ratio of 37.91, a price-to-earnings-growth ratio of 2.63 and a beta of 0.74.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter last year, the firm earned $6.27 earnings per share. The firm's quarterly revenue was up 26.2% compared to the same quarter last year. On average, analysts anticipate that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana's dividend payout ratio (DPR) is presently 33.49%.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source